SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation
9 references·3 citing·29 second hop
HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation (2003)HIV antibody screening remains indispensa…Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe (2002)Yield of HCV and HIV‐1 NAT af…Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 2000 (2002)Trends in residual risk of tr…Residual risk of transfusion‐transmitted HCV and HIV infections by antibody‐screened blood in Italy (2002)Residual risk of transfusion‐…International application of the Incidence Rate/Window Period model (2002)International application of …Estimated risk of transfusion‐transmitted viral infections in Spain (2002)Estimated risk of transfusion…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Nucleic acid amplification te…Failure of Routine HIV-1 Tests in a Case Involving Transmission With Preseroconversion Blood Components During the Infectious Window Period (2000)Failure of Routine HIV-1 Test…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Molecular virology in transfusion medicine laboratory. (2013)Molecular virology in transfu…Comparison of HIV-1 detection in plasma specimens and dried blood spots using the Roche COBAS Ampliscreen HIV-1 test in Kisumu, Kenya (2011)Comparison of HIV-1 detection…Antigen‐antibody combination assays for blood donor screening: weighing the advantages and costs (2008)Antigen‐antibody combination …Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)NAT of the United States and Canadian blood supply (2000)Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Effect of a National Disaster on Blood Supply and Safety (2003)Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. (2003)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Performance of parallel screening of Brazilian blood donors with two human immunodeficiency virus immunoassays: implications for sequential immunoassay testing algorithms in other countries (2010)Quarantine Plasma: Quo vadis? (2010)Overview of Blood Mixers for Transfusion Therapy: Characteristics, Features, and Development Potential (2020)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Window‐period human immunodeficiency virus transmission to two recipients by an adolescent blood donor (2004)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Nucleic acid testing (NAT) in high prevalence–low resource settings (2010)False-Positive HIV-1 Test Results in a Low-Risk Screening Setting of Voluntary Blood Donation (1998)NAT and blood safety: what is the paradigm? (2000)First report of human immunodeficiency virus transmission via an RNA‐screened blood donation (2004)10.1016/s0000-0000(03)47688-2 (2000)Risque résiduel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du dépistage génomique viral (2004)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy (2005)Biological qualification of blood units (2004)Residual infectious disease risk in screened blood transfusion from a high‐prevalence population: Santa Catarina, Brazil (2007)Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Prevention of transfusion-transmitted infections (2019)Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010 (2012)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 2000Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases218 cited
  • 2002International application of the Incidence Rate/Window Period model150 cited
  • 2000Failure of Routine HIV-1 Tests in a Case Involving Transmission With Preseroconversion Blood Components During the Infectious Window Period108 cited
  • 2002Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 200098 cited
  • 2002Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe91 cited
  • 2002Estimated risk of transfusion‐transmitted viral infections in Spain69 cited
  • 2002Residual risk of transfusion‐transmitted HCV and HIV infections by antibody‐screened blood in Italy45 cited

Cited by

  • 2008Antigen‐antibody combination assays for blood donor screening: weighing the advantages and costs22 cited
  • 2013Molecular virology in transfusion medicine laboratory.15 cited
  • 2011Comparison of HIV-1 detection in plasma specimens and dried blood spots using the Roche COBAS Ampliscreen HIV-1 test in Kisumu, Kenya8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work